Skip to main content

Articles

Page 6 of 76

  1. Glioma is the most common and lethal type of brain tumor, and it is characterized by unfavorable prognosis and high recurrence rates. The reprogramming of energy metabolism and an immunosuppressive tumor micro...

    Authors: Shupeng Li, Ziwei Li, Xinyu Wang, Junzhe Zhong, Daohan Yu, Hao Chen, Wenbin Ma, Lingling Liu, Minghuang Ye, Ruofei Shen, Chuanlu Jiang, Xiangqi Meng and Jinquan Cai
    Citation: Cancer Cell International 2023 23:227
  2. N6-methyladenosine(m6A), is the most abundant post-transcriptional modification of mRNA in biology. When the first nucleotide after the m7G cap is adenosine, it is methylated at the N6 position to form N6,2-O-...

    Authors: Yuting Wu, Xi Pu, Sihui Wu, Yiran Zhang, Shengqiao Fu, Haowen Tang, Xu Wang and Min Xu
    Citation: Cancer Cell International 2023 23:226
  3. Post-translational modifications (PTMs) of proteins contribute to the occurrence and development of tumors. Previous studies have suggested that canonical PTMs such as ubiquitination, glycosylation, and phosph...

    Authors: Yihong Liu, Jingwei Liu, Na Peng, Shuangshuang Hai, Shen Zhang, Haibo Zhao and Weixin Liu
    Citation: Cancer Cell International 2023 23:225
  4. Hyper progressive disease (HPD) describes the phenomenon that patients can’t benefit from immunotherapy but cause rapid tumor progression. HPD is a particular phenomenon in immunotherapy but lacks prediction m...

    Authors: Yaping Long, Wenyu Yang, Yibing Bai, Haitao Tao, Fan Zhang, Lijie Wang, Bo Yang, Di Huang, Xiao Han and Yi Hu
    Citation: Cancer Cell International 2023 23:224
  5. High-grade serous ovarian cancer (HGSOC) is a challenging malignancy characterized by complex interactions between tumor cells and the surrounding microenvironment. Understanding the immune landscape of HGSOC,...

    Authors: Qihui Wu, Xiaoyun He, Jiaxin Liu, Chunlin Ou, Yimin Li and Xiaodan Fu
    Citation: Cancer Cell International 2023 23:223
  6. According to the latest epidemiological investigation, lung adenocarcinoma (LUAD) is one of the most fatal cancer among both men and women. Despite continuous advancements in treatment approaches in recent yea...

    Authors: Pengdou Zheng, Zhenyu Mao, Miao Luo, Ling Zhou, Lingling Wang, Huiguo Liu, Wei Liu and Shuang Wei
    Citation: Cancer Cell International 2023 23:222
  7. Bladder cancer (BCa) is one of the most common malignancies worldwide. However, the lack of accurate and effective targeted drugs has become a major problem in current clinical treatment of BCa. Studies have d...

    Authors: Fan Zou, Wu Chen, Tianbao Song, Ji Xing, Yunlong Zhang, Kang Chen, Weimin Hu, Linzhi Li, Jinzhuo Ning, Chenglong Li, Weimin Yu and Fan Cheng
    Citation: Cancer Cell International 2023 23:221
  8. Myosin heavy chain 9 (MYH9) plays an important role in a number of diseases. Nevertheless, the function of MYH9 in glioma is unclear. The present research aimed to investigate the role of MYH9 in glioma and de...

    Authors: Zigui Chen, Xin Yan, Changfeng Miao, Longyang Liu, Su Liu, Ying Xia, Weiyi Fang, Dandan Zheng and Qisheng Luo
    Citation: Cancer Cell International 2023 23:220
  9. Recently, natural killer (NK) cells emerged as a treatment option for various solid tumors. However, the immunosuppressive tumor immune microenvironment (TIME) can reduce the cytotoxic ability of NK cells in p...

    Authors: Hyun-Ah Kim, Hyunsoo Kim, Min-Kyung Nam, Jong Kook Park, Moo-Yeal Lee, Seok Chung, Kyung-Mi Lee and Hyo-Jeong Kuh
    Citation: Cancer Cell International 2023 23:219
  10. Disulfidptosis is independent of apoptosis, ferroptosis, and cuproptosis and is associated with cancer progression, treatment response, and prognosis. However, the predictive potential of disulfidptosis-associ...

    Authors: Weijie Xue, Kang Qiu, Bingzi Dong, Dong Guo, Junhua Fu, Chengzhan Zhu and Zhaojian Niu
    Citation: Cancer Cell International 2023 23:218
  11. The aim of this study was to determine the underlying potential mechanisms and function of DIO3OS, a lincRNA in osteosarcoma and clarify that DIO3OS can be used as a potential diagnostic biomarker and immunoth...

    Authors: Jinghong Yuan, Jingyu Jia, Tianlong Wu, Zhi Du, Qi Chen, Jian Zhang, Zhiwen Wu, Zhao Yuan, Xiaokun Zhao, Jiahao Liu, Jia Guo and Xigao Cheng
    Citation: Cancer Cell International 2023 23:215
  12. Immunoblockade therapy based on the PD-1 checkpoint has greatly improved the survival rate of patients with skin cutaneous melanoma (SKCM). However, existing anti-PD-1 therapeutic efficacy prediction markers o...

    Authors: Shaolong Leng, Gang Nie, Changhong Yi, Yunsheng Xu, Lvya Zhang and Linyu Zhu
    Citation: Cancer Cell International 2023 23:214
  13. Luteolin is an active ingredient in various traditional Chinese medicines for the treatment of multiple tumors. However, the mechanisms of its inhibitory effect on osteosarcoma proliferation and metastasis rem...

    Authors: Renxuan Huang, Mingxian Xu, Weitang Guo, Mingzhe Cheng, Rui Dong, Jian Tu, Shao Xu and Changye Zou
    Citation: Cancer Cell International 2023 23:213
  14. Research studies have demonstrated that Midkine (MDK) can influence the expression and activity of Renin-angiotensin system (RAS) components. Angiotensin II is involved in tumor growth and angiogenesis in diff...

    Authors: Tai-Jan Chiu, Chang-Han Chen, Yi-Ju Chen, Yinshen Wee, Ching-Shuen Wang and Sheng‑Dean Luo
    Citation: Cancer Cell International 2023 23:212
  15. Pancreatic cancer is one of the leading causes of cancer death in Western societies. Its late diagnosis and resistance to chemotherapies result in a high mortality rate; thus, the development of more effective...

    Authors: Mariola Gimła, Agnieszka Pyrczak-Felczykowska, Marcelina Malinowska, Aleksandra Hać, Magdalena Narajczyk, Irena Bylińska, Tristan A. Reekie and Anna Herman-Antosiewicz
    Citation: Cancer Cell International 2023 23:210
  16. Lung cancer is a leading cause of cancer-related deaths, and the most common type is lung adenocarcinoma (LUAD). LUAD is frequently diagnosed in people who never smoked, patients are always diagnosed at advanc...

    Authors: Xu Lin, Ye-han Liu, Huan-qi Zhang, Lin-wen Wu, Qi Li, Jun Deng, Qingyi Zhang, Yuhong Yang, Chong Zhang, Yang-ling Li and Jian Hu
    Citation: Cancer Cell International 2023 23:208
  17. Lung cancer has the highest mortality rate in the world, and mounting evidence suggests that cancer stem cells (CSCs) are associated with poor prognosis, recurrence, and metastasis of lung cancer. It is urgent...

    Authors: Chia-Hao Tung, Jia-En Wu, Meng-Fan Huang, Wen-Lung Wang, Yi-Ying Wu, Yao-Tsung Tsai, Xiu-Rui Hsu, Sheng-Hsiang Lin, Yuh-Ling Chen and Tse-Ming Hong
    Citation: Cancer Cell International 2023 23:207
  18. Lymphangiogenesis has been reported to play crucial roles in the metastasis of thyroid cancer (THCA), but despite the significant research on lymphangiogenesis in THCA, the precise regulatory mechanism remains...

    Authors: Liyun Yang, Runyu Zhao, Peipei Qiao, Jiaxin Cui, Xiaoping Chen, Jinping Fan, An Hu and Shuixian Huang
    Citation: Cancer Cell International 2023 23:206
  19. Hepatocellular Carcinoma (HCC) possesses the high mortality in cancers worldwide. Nevertheless, the concrete mechanism underlying HCC proliferation remains obscure. In this study, we show that high expression ...

    Authors: Yabing Hu, Yongchu Huang, Xiaohang Xie, Longshan Li, Yong Zhang and Xiaochao Zhang
    Citation: Cancer Cell International 2023 23:205
  20. Triple negative breast cancer (TNBC) represents a significant clinical challenge. Chemotherapy remains the mainstay for a large part of TNBC patients, whereas drug resistance and tumor recurrence frequently oc...

    Authors: Hui Lyu, Fei Shen, Sanbao Ruan, Congcong Tan, Jundong Zhou, Ann D. Thor and Bolin Liu
    Citation: Cancer Cell International 2023 23:204
  21. Outcomes for patients with relapsed acute lymphoblastic leukemia (ALL) are poor and there is a need for novel therapies to improve outcomes. Targeted inhibition of WEE1 with small-molecule inhibitor adavoserti...

    Authors: Hayden L. Bell, Helen J. Blair, Mankaran Singh, Anthony V. Moorman, Olaf Heidenreich, Frederik W. van Delft, John Lunec and Julie A. E. Irving
    Citation: Cancer Cell International 2023 23:202
  22. A growing body of evidence indicates that the anticancer effect of the immune system can be activated by the immunogenic modulation of dying cancer cells. Cancer cell death, as a result of the activation of an...

    Authors: Mina Amiri, Ommoleila Molavi, Shahnaz Sabetkam, Sevda Jafari and Soheila Montazersaheb
    Citation: Cancer Cell International 2023 23:200
  23. Hepatitis B virus (HBV)-encoded X antigen, HBx, assists in the development of hepatocellular carcinoma (HCC) through complex mechanisms. Our results provide new insights into the EZH2 epigenetic repression of ...

    Authors: Chen-Shiou Wu, Yi-Chung Chien, Chia‐Jui Yen, Jia-Yan Wu, Li-Yuan Bai and Yung-Luen Yu
    Citation: Cancer Cell International 2023 23:199
  24. Small nucleolar RNA host gene 1 (SNHG1) is an important member of the SNHG family. This family is composed of a group of host genes that can be processed into small nucleolar RNAs and play important biological...

    Authors: Huang Zeng, Shouang Zhou, Weiqiang Cai, Mingqiang Kang and Peipei Zhang
    Citation: Cancer Cell International 2023 23:198
  25. Telomerase can overcome replicative senescence by elongation of telomeres but is also a specific element in most cancer cells. It is expressed more vastly than any other tumor marker. Telomerase as a tumor tar...

    Authors: Jaber Haj Ali and Michael Walter
    Citation: Cancer Cell International 2023 23:197
  26. The prognosis of tumor patients can be assessed by measuring the levels of lncRNAs (long non-coding RNAs), which play a role in controlling the methylation of the RNA. Prognosis in individuals with colorectal ...

    Authors: Ziyang Di, Gaoran Xu, Zheyu Ding, Chengxin Li, Jialin Song, Guoquan Huang, Jinsen Zheng, Xinyao Zhang and Bin Xiong
    Citation: Cancer Cell International 2023 23:196
  27. Polypyrimidine tract binding protein 1 (PTBP1) has been found to play an important role in the occurrence and development of various tumors. At present, the role of PTBP1 in gastric cancer (GC) is still unknow...

    Authors: Zewen Chu, Miao Zhu, Yuanyuan Luo, Yaqi Hu, Xinyi Feng, Haibo Wang, Masataka Sunagawa and Yanqing Liu
    Citation: Cancer Cell International 2023 23:195
  28. Lung adenocarcinoma (LUAD) exhibits a higher fatality rate among all cancer types worldwide, yet the precise mechanisms underlying its initiation and progression remain unknown. Mounting evidence suggests that...

    Authors: Liyao Dong, Lin Zhang, Xinyun Zhao, Hongling Zou, Sisi Lin, Xinping Zhu, Jili Cao, Chun Zhou, Zhihong Yu, Yongqiang Zhu, Kequn Chai, Mingqian Li and Qun Li
    Citation: Cancer Cell International 2023 23:194
  29. In recent years, several bispecific antibodies (BsAbs) have been introduced that revolutionized the treatment approach for patients with multiple myeloma (MM). In the present study, we sought for conducting a ...

    Authors: Maryam Noori, Niloufar Yazdanpanah and Nima Rezaei
    Citation: Cancer Cell International 2023 23:193
  30. Approximately 50% of patients with primary colorectal carcinoma develop liver metastases. This study investigates the possible molecular discrepancies between primary colorectal cancer (pCRC) and their respect...

    Authors: Hersh Ham-Karim, Ola Negm, Narmeen Ahmad and Mohammad Ilyas
    Citation: Cancer Cell International 2023 23:192
  31. Progranulin (PGRN), a glycoprotein secreted by a wide range of epithelial cells and plays an important role in inflammatory mechanisms and tumor progression. In this study, the expression, and functions of PGR...

    Authors: Yanxu Dong, Hao Tan, Lidong Wang and Zhen Liu
    Citation: Cancer Cell International 2023 23:191
  32. Docetaxel (DTX) resistance reduces therapeutic efficacy in prostate cancer (PCa). Accumulating reports support the role of phytochemicals in the reversal of DTX resistance. This study aimed to determine whether E...

    Authors: Wenjing Xu, Jin Ding, Shida Kuang, Bonan Li, Tiansong Sun, Congxu Zhu, Juan Liu, Lemei Zhu, Yingqiu Li and Wen Sheng
    Citation: Cancer Cell International 2023 23:190
  33. The tumor vasculature was different from the normal vasculature in both function and morphology, which caused hypoxia in the tumor microenvironment (TME). Previous anti-angiogenesis therapy had led to a modest...

    Authors: Yang Li, Lei Fu, Baokang Wu, Xingqi Guo, Yu Shi, Chao Lv, Yang Yu, Yizhou Zhang, Zhiyun Liang, Chongli Zhong, Shukun Han, Feng Xu and Yu Tian
    Citation: Cancer Cell International 2023 23:189
  34. The long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been reported to play a vital role in the occurrence and development of various tumors. However, the underlying mecha...

    Authors: Guang-Zhen Li, Guang-Xiao Meng, Guo-Qiang Pan, Xiao Zhang, Lun-Jie Yan, Rui-Zhe Li, Zi-Niu Ding, Si-Yu Tan, Dong-Xu Wang, Bao-wen Tian, Yu-Chuan Yan, Zhao-Ru Dong, Jian-Guo Hong and Tao Li
    Citation: Cancer Cell International 2023 23:188
  35. To date, data on the efficacy of targeted therapies for mucosal melanoma (MM) are limited. In this study, we analyzed genetic alterations according to the primary site of origin, which could provide clues for ...

    Authors: Hai-Yun Wang, Ye Liu, Ling Deng, Kuntai Jiang, Xin-Hua Yang, Xiao-Yan Wu, Kai-Hua Guo and Fang Wang
    Citation: Cancer Cell International 2023 23:187
  36. Renal cell carcinoma (RCC) is a hypermetabolic disease. Abnormal up-regulation of glycolytic signaling promotes tumor growth, and glycolytic metabolism is closely related to immunotherapy of renal cancer. The ...

    Authors: Sichen Di, Min Gong, Jianmin Lv, Qiwei Yang, Ye Sun, Yijun Tian, Cheng Qian, Wenjin Chen, Wang Zhou, Keqin Dong, Xiaokai Shi, Yuning Wang, Hongru Wang, Jian Chu, Sishun Gan, Xiuwu Pan…
    Citation: Cancer Cell International 2023 23:186
  37. The transferrin receptor (TfR) encoded by TFRC gene is the main cellular iron importer. TfR is highly expressed in many cancers and is expected to be a promising new target for cancer therapy; however, its role i...

    Authors: Guofei Feng, Yasushi Arima, Kaoru Midorikawa, Hatasu Kobayashi, Shinji Oikawa, Weilin Zhao, Zhe Zhang, Kazuhiko Takeuchi and Mariko Murata
    Citation: Cancer Cell International 2023 23:185
  38. Across the world, oral cancer is a prevalent tumor. Over the years, both its mortality and incidence have grown. Oral cancer metastasis is a complex process involving cell invasion, migration, proliferation, a...

    Authors: Meghdad Eslami, Saba Khazeni, Xaniar Mohammadi Khanaghah, Mohammad Hossein Asadi, Mohamad Amin Ansari, Javad Hayati Garjan, Mohammad Hassan Lotfalizadeh, Mobina Bayat, Mohammad Taghizadieh, Seyed Pouya Taghavi, Michael R Hamblin and Javid Sadri Nahand
    Citation: Cancer Cell International 2023 23:182
  39. Dietary compounds in cancer prevention have gained significant consideration as a viable method. Indole-3-carbinol (I3C) and 3,3′-diindolylmethane (DIM) are heterocyclic and bioactive chemicals found in crucif...

    Authors: Octavio Daniel Reyes-Hernández, Gabriela Figueroa-González, Laura Itzel Quintas-Granados, Stephany Celeste Gutiérrez-Ruíz, Hector Hernández-Parra, Alejandra Romero-Montero, María Luisa Del Prado-Audelo, Sergio Alberto Bernal-Chavez, Hernán Cortés, Sheila I. Peña-Corona, Lashyn Kiyekbayeva, Dilek Arslan Ateşşahin, Tamar Goloshvili, Gerardo Leyva-Gómez and Javad Sharifi-Rad
    Citation: Cancer Cell International 2023 23:180
  40. Unlike improved treatment response in multiple myeloma (MM), the mortality rate in MM is still high. The study’s aim is to investigate the potential role of circRNAs as a new biomarker for diagnosis, prognosis...

    Authors: Yasin Mirazimi, Amir Hossein Aghayan, Abbasali Keshtkar, Mahsa Mottaghizadeh Jazi, Atefeh Davoudian and Mohammad Rafiee
    Citation: Cancer Cell International 2023 23:178

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.6 - 5-year Impact Factor
    0.994 - SNIP (Source Normalized Impact per Paper)
    1.145 - SJR (SCImago Journal Rank)

    2023 Speed
    34 days submission to first editorial decision for all manuscripts (Median)
    110 days submission to accept (Median)

    2023 Usage 
    2,067,719 downloads
    1,052 Altmetric mentions 

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here